NCT04219579View on ClinicalTrials.gov

Antithrombin III Concentrate After Liver Transplantation

NACompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

January 3, 2020

Primary Completion Date

June 28, 2022

Study Completion Date

June 30, 2022

Conditions
Liver Transplant; Complications
Interventions
DRUG

Antithrombin III, continuous infusion

Antithrombin-III is administered continuously

DRUG

Antithrombin III, Intermittent infusion

Antithrombin-III is administered intermittently

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT04219579 - Antithrombin III Concentrate After Liver Transplantation | Biotech Hunter | Biotech Hunter